FDA approves Lanett's muscle relaxant drug: 3 things to know

The Food and Drug Administration approved Philadelphia-based Lannett's metaxalone tablets.

Here are three things to know.

1. The drug is a muscle relaxant intended to treat patients with acute, painful musculoskeletal conditions.

2. Metaxalone tablets are a generic version of King Pharmaceuticals' drug Skelaxin.

3. Lannett plans to launch the drug this quarter.

More articles on supply chain:

Court orders contracted pilots for Amazon, DHL to return to work after strike
Medisafe and TimerCap launch Bluetooth-enabled pill bottle to track medication adherence
Demand for durable manufactured goods rose 4.8% in October — largest jump in a year


Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars